Clinical and genetic outcome determinants of Internet‐ and group‐based cognitive behavior therapy for social anxiety disorder

Hedman E, Andersson E, Ljótsson B, Andersson G, Andersson E, Schalling M, Lindefors N, Rück C. Clinical and genetic outcome determinants of Internet‐ and group‐based cognitive behavior therapy for social anxiety disorder (SAD).

[1]  K. Roelofs,et al.  Positive and negative life events and personality traits in predicting course of depression and anxiety , 2011, Acta psychiatrica Scandinavica.

[2]  D. Collier,et al.  Therapygenetics: The 5HTTLPR and response to psychological therapy , 2011, Molecular Psychiatry.

[3]  E. Vázquez.  To your health. , 2011, Positively aware : the monthly journal of the Test Positive Aware Network.

[4]  G. Andersson,et al.  Internet-Based Cognitive Behavior Therapy vs. Cognitive Behavioral Group Therapy for Social Anxiety Disorder: A Randomized Controlled Non-inferiority Trial , 2011, PloS one.

[5]  Gerhard Andersson,et al.  The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder , 2010, BMC psychiatry.

[6]  P. Cuijpers,et al.  The course of untreated anxiety and depression, and determinants of poor one-year outcome: a one-year cohort study , 2010, BMC psychiatry.

[7]  H. Sexton,et al.  Predictors of outcome in residential cognitive and interpersonal treatment for social phobia: do cognitive and social dysfunction moderate treatment outcome? , 2010, Journal of behavior therapy and experimental psychiatry.

[8]  K. Felmingham,et al.  Preliminary Evidence of the Short Allele of the Serotonin Transporter Gene Predicting Poor Response to Cognitive Behavior Therapy in Posttraumatic Stress Disorder , 2010, Biological Psychiatry.

[9]  L. Hetem,et al.  Social anxiety disorder: what are we losing with the current diagnostic criteria? , 2010, Acta psychiatrica Scandinavica.

[10]  G. Glover,et al.  A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human , 2010, Science.

[11]  Thomas L. Patterson,et al.  The Relationship Between Homework Compliance and Therapy Outcomes: An Updated Meta-Analysis , 2010, Cognitive Therapy and Research.

[12]  E. Hougaard,et al.  Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review , 2010, Nordic journal of psychiatry.

[13]  G. Andersson,et al.  Guided and unguided self-help for social anxiety disorder: randomised controlled trial. , 2009, The British journal of psychiatry : the journal of mental science.

[14]  N. Risch,et al.  Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. , 2009, JAMA.

[15]  N. Titov,et al.  Shyness 3: Randomized Controlled Trial of Guided Versus Unguided Internet-Based CBT for Social Phobia , 2008, The Australian and New Zealand journal of psychiatry.

[16]  Sati Mazumdar,et al.  Empirically derived decision trees for the treatment of late-life depression. , 2008, The American journal of psychiatry.

[17]  M. Antony,et al.  Group cohesion in cognitive-behavioral group therapy for social phobia. , 2007, Behaviour research and therapy.

[18]  D. Clark,et al.  Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial , 2007, Acta psychiatrica Scandinavica.

[19]  G. Andersson,et al.  Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial. , 2006, Journal of consulting and clinical psychology.

[20]  M. Stein,et al.  Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder , 2006, Psychopharmacology.

[21]  E. Favaron,et al.  Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter Gene , 2005, Neuropsychopharmacology.

[22]  Andreas Heinz,et al.  Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex , 2005, The Journal of Neuroscience.

[23]  Anil K Malhotra,et al.  Pharmacogenetics of psychotropic drug response. , 2004, The American journal of psychiatry.

[24]  J. Raloff.  To your health?: Controversy surrounds whole-body scans—a costly screen for silent threats , 2003 .

[25]  Ronald C. Kessler,et al.  The impairments caused by social phobia in the general population: implications for intervention , 2003, Acta psychiatrica Scandinavica. Supplementum.

[26]  R. Heimberg,et al.  Non‐pharmacologic treatments for social anxiety disorder , 2003, Acta psychiatrica Scandinavica. Supplementum.

[27]  H. Kraemer,et al.  Mediators and moderators of treatment effects in randomized clinical trials. , 2002, Archives of general psychiatry.

[28]  Richard G. Heimberg,et al.  Cognitive-Behavioral Group Therapy for Social Phobia: Basic Mechanisms and Clinical Strategies , 2002 .

[29]  S. Hofmann,et al.  The liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis. , 2002, Behaviour research and therapy.

[30]  T. Furmark,et al.  Social phobia: overview of community surveys , 2002, Acta psychiatrica Scandinavica.

[31]  H Bergman,et al.  Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data , 2000, Acta psychiatrica Scandinavica.

[32]  M. Liebowitz,et al.  Psychometric properties of the Liebowitz Social Anxiety Scale , 1999, Psychological Medicine.

[33]  D. Klein,et al.  Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. , 1998, Archives of general psychiatry.

[34]  D. Greenberg,et al.  The treatment of social phobia: a critical assessment , 1998, Acta psychiatrica Scandinavica.

[35]  Jeffrey L. Geller,et al.  Social Phobia: Diagnosis, Assessment, and Treatment , 1997 .

[36]  C. R. Glass,et al.  Predictors of response to cognitive-behavioral group therapy for social phobia. , 1997, Journal of anxiety disorders.

[37]  T. Allan,et al.  On predicting improvement and relapse in generalized anxiety disorder following psychotherapy. , 1997, The British journal of clinical psychology.

[38]  C. Schaap,et al.  Predictors of Treatment Outcome in the Behavioural Treatment of Obsessive-Compulsive Disorder , 1994, British Journal of Psychiatry.

[39]  P. Svanborg,et al.  A new self‐rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale , 1994, Acta psychiatrica Scandinavica.

[40]  John E. Cornell,et al.  Clinical Validation of the Quality of Life Inventory: A Measure of Life Satisfaction for Use in Treatment Planning and Outcome Assessment , 1992 .

[41]  N. Jacobson,et al.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.

[42]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[43]  G. Holmlund,et al.  Rapid DNA purification for restriction fragment length polymorphism analysis. , 1988, Gene analysis techniques.

[44]  T. Borkovec,et al.  Credibility of analogue therapy rationales , 1972 .

[45]  S. Hollon,et al.  Predicting outcome in computerized cognitive behavioral therapy for depression in primary care: A randomized trial. , 2010, Journal of consulting and clinical psychology.

[46]  T. Furmark.  Neurobiological aspects of social anxiety disorder. , 2009, The Israel journal of psychiatry and related sciences.

[47]  Daniel S Pine,et al.  Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder. , 2008, The American journal of psychiatry.

[48]  S. Hofmann,et al.  Treatment attrition during group therapy for social phobia. , 2006, Journal of anxiety disorders.

[49]  J. Ramnerö.  Behavioral Treatments of Panic Disorder with Agoraphobia : Treatment Process and Determinants of Change , 2005 .

[50]  Jonas Ramnero.  Behavioral Treatments of Panic Disorder with Agoraphobia: Treatment Process and Determinants of Change: (530352013-001) , 2005 .

[51]  M. First,et al.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .

[52]  G. Holmbeck.  Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and pediatric psychology literatures. , 1997, Journal of consulting and clinical psychology.

[53]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[54]  G. Steketee,et al.  Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder , 1995 .

[55]  A. Wells.  A cognitive model of social phobia , 1995 .

[56]  Larry E. Toothaker,et al.  Multiple Regression: Testing and Interpreting Interactions , 1991 .